Topic List : Cancer
Fibrotic diseases united by common pathway
A common signaling pathway unites diverse fibrotic diseases in humans, Stanford researchers have found. An antibody called anti-CD47, which is being tested as an anti-cancer agent, reverses fibrosis in mice.
Too many unnecessary double mastectomies?
Women with breast cancer do not receive timely genetic testing or have adequate access to effective genetic counseling, which may compromise treatment decisions, according to research from Stanford and the University of Michigan.
Ronald Levy and Howard Chang honored
Stanford cancer researchers Ronald Levy and Howard Chang have been named Outstanding Investigators by the National Cancer Institute. They were awarded grants of up to $7 million over six years to advance their studies.
Diagnosing cancer without biopsy
A Stanford-led team of researchers has developed tiny bubbles that bind to malignant tumors, making them visible to ultrasound imaging.
Grants awarded for cancer immunotherapy
The Parker Institute for Cancer Immunotherapy at Stanford hands out its first grants to researchers who hope to translate scientific discoveries into new therapies for cancer patients.
Antibody effective against brain tumors
Antibodies against the CD47 “don’t eat me” signal were shown in mice to be a safe and effective way to target five kinds of pediatric brain tumors, according to Stanford researchers.
Podcast: The relationship between science and magic
When he’s not developing computer models to improve cancer detection, Parag Mallick, PhD, is juggling fire, walking on stilts or mastering card tricks. In this podcast, he talks about how he became a member of a professional performance troupe and the relationship between science and magic.
Heart-damaging chemo drugs ranked
Stanford researchers have developed a test that may help screen for cardiotoxicity in new chemotherapy drugs.
Algorithm can identify skin cancer
In the hope of creating better access to medical care, Stanford researchers have trained an algorithm to diagnose skin cancer.
Many breast cancer patients ‘undertested’
Physicians often fail to recommend genetic testing to breast cancer patients at high risk for cancer-associated mutations. Improving access to genetic counseling about the testing process and results is a key priority.